×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
复旦大学上海医学院 [21]
武汉大学 [9]
北京大学 [3]
大连理工大学 [1]
上海药物研究所 [1]
西北高原生物研究所 [1]
更多...
内容类型
期刊论文 [24]
会议论文 [12]
其他 [3]
发表日期
2021 [1]
2019 [5]
2018 [3]
2017 [7]
2016 [5]
2015 [2]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共39条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Molecular characterization and functional properties of avenin-like b gene TuALPb7As in Triticum urartu
期刊论文
BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT, 2021, 卷号: 35, 期号: 1
作者:
Cao, Dong
;
Ye, Fahui
;
Zhao, Caixia
;
Shen, Jicheng
;
Liu, Ruijuan
收藏
  |  
浏览/下载:24/0
  |  
提交时间:2021/11/18
Triticum urartu
avenin-like b gene
TuALPb7A
genetic diversity
dough properties
Determination of DP-VPA and its active metabolite, VPA, in human plasma, urine, and feces by UPLC-MS/MS: A clinical pharmacokinetics and excretion study
期刊论文
DRUG TESTING AND ANALYSIS, 2019, 卷号: 11, 期号: 7
作者:
Li, Yi
;
Zhan, Huizhong
;
Fan, Yaxin
;
Zhang, Jing
;
Cao, Guoying
收藏
  |  
浏览/下载:33/0
  |  
提交时间:2019/12/05
DP-VPA
epilepsy
excretion
pharmacokinetics
UPLC-MS
MS
HS016, A PROPOSED ADALIMUMAB BIOSIMILAR, SHOWED EQUIVALENT PHARMACOKINETICS AND SIMILAR SAFETY, IMMUNOGENICITY AND TOLERABILITY TO CHINA-LICENSED ADALIMUMAB IN HEALTHY MALE SUBJECTS, ACCORDING TO A 2.3-MONTHS PHASE I STUDY
会议论文
作者:
Cao, Guoying
;
Yu, Jicheng
;
Wang, Jingjing
;
Yang, Xiaoli
;
Xue, Yu
收藏
  |  
浏览/下载:17/0
  |  
提交时间:2019/12/05
Tolerability and Pharmacokinetics of Contezolid at Therapeutic and Supratherapeutic Doses in Healthy Chinese Subjects, and Assessment of Contezolid Dosing Regimens Based on Pharmacokinetic/Pharmacodynamic Analysis
期刊论文
CLINICAL THERAPEUTICS, 2019, 卷号: 41, 期号: 6
作者:
Wu, Junzhen
;
Wu, Hailan
;
Wang, Yu
;
Chen, Yuancheng
;
Guo, Beining
收藏
  |  
浏览/下载:28/0
  |  
提交时间:2019/12/05
contezolid
MRX-I
pharmacokinetic-pharmacodynamic
pharmacokinetics
supra-therapeutic doses
tolerability
Determination of DP-VPA and its active metabolite, VPA, in human plasma, urine, and feces by UPLC-MS/MS: a clinical pharmacokinetics and excretion study.
期刊论文
Drug testing and analysis, 2019
作者:
Yi Li
;
Huizhong Zhan
;
Yaxin Fan
;
Jing Zhang
;
Guoying Cao
收藏
  |  
浏览/下载:24/0
  |  
提交时间:2019/12/17
DP-VPA
UPLC-MS/MS
epilepsy
excretion
pharmacokinetics
valproic acid
Climate change has weakened the ability of Chinese lakes to bury polycyclic aromatic hydrocarbons
期刊论文
ENVIRONMENTAL POLLUTION, 2019, 卷号: 255
作者:
Tao, Yuqiang
;
Zhang, Ya
;
Cao, Jicheng
;
Wu, Zifan
;
Yao, Shuchun
收藏
  |  
浏览/下载:32/0
  |  
提交时间:2020/09/16
Short-term Safety, Tolerability, and Pharmacokinetics of MRX-I, an Oxazolidinone Antibacterial Agent, in Healthy Chinese Subjects
期刊论文
CLINICAL THERAPEUTICS, 2018, 卷号: 40, 期号: 2
作者:
Wu, Xiaojie
;
Li, Yunfei
;
Zhang, Jing
;
Zhang, Yingyuan
;
Yu, Jicheng
收藏
  |  
浏览/下载:11/0
  |  
提交时间:2019/12/05
healthy subjects
MRX-I
pharmacokinetics
safety
Determination of the sulfate and glucuronide conjugates of levornidazole in human plasma and urine, and levornidazole and its five metabolites in human feces by high performance liquid chromatography-tandem mass spectrometry
期刊论文
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2018, 卷号: 1081
作者:
He, Gaoli
;
Guo, Beining
;
Zhang, Jing
;
Li, Yi
;
Wu, Xiaojie
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2019/12/05
Levornidazole
Metabolites
LC-MS/MS
Validation
Biological samples
Similarity-maintaining Privacy Preservation and Location-aware Low-rank Matrix Factorization for QoS Prediction based Web Service Recommendation
期刊论文
IEEE Transactions on Services Computing, 2018
作者:
Zhu, Xiaoke
;
Jing, Xiao-Yuan
;
Wu, Di
;
He, Zhenyu
;
Cao, Jicheng
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2019/12/05
Clinical Pharmacokinetics of Levornidazole in Elderly Subjects and Dosing Regimen Evaluation Using Pharmacokinetic/Pharmacodynamic Analysis
期刊论文
CLINICAL THERAPEUTICS, 2017, 卷号: 39, 期号: 7
作者:
Guo, Beining
;
He, Gaoli
;
Wu, Xiaojie
;
Yu, Jicheng
;
Cao, Guoying
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/12/05
dosing regimen evaluation
elderly subject
levornidazole
metabolite
pharmacokinetics
©版权所有 ©2017 CSpace - Powered by
CSpace